drugset / Trial / NCT00285350
Mycophenolate Mofetil in Myasthenia Gravis
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a prospective, multi-center, double-blind, placebo-controlled trial to determine the efficacy and safety of mycophenolate mofetil (MM) in combination with prednisone as the initial form of immunosuppression in patients with acquired myasthenia gravis (MG).
Timeline
- Start
- 2002-09
- Primary completion
- —
- Completion
- 2007-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mycophenolate Mofetil | Small molecule | 1250 mg | — |